Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Exploring the link between menstrual cycles and urinary incontinence in women with spinal cord injuries

Official title: Urine Incontinence Occurrence and Sexual Hormones in Women With Chronic Spinal Cord Injury/Disease - a Pilot Study

Run by Swiss Paraplegic Research, Nottwil · NCT06892080 · Data updated 2026-11-12

This study looks at how changes in hormones during the menstrual cycle might affect bladder control in women with spinal cord injuries to see if it can help improve treatment options.

More Spinal Cord Injury trials

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment24 (estimated)
SponsorSwiss Paraplegic Research, Nottwil
Research network
Locations1 site (Nottwil)
StatusRecruiting
StartedJuly 1, 2025
Main results expectedJuly 31, 2029
Study endsNovember 30, 2029
Registry record updatedSeptember 10, 2026
Trial IDNCT06892080 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 and older with chronic neurogenic bladder dysfunction due to spinal cord injury and a regular menstrual cycle.

Probably not a fit

Patients who have hormonal imbalances, such as oligomenorrhea or amenorrhea, or those on hormonal treatments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational pilot study investigates how fluctuations in sex hormones during the menstrual cycle may affect bladder function in women with chronic spinal cord injury. Participants will document their menstrual cycles and instances of urinary incontinence over three cycles, using diaries, saliva samples, and urine tests to gather data. The goal is to identify potential hormonal influences on urinary incontinence, which has been less studied in premenopausal women compared to postmenopausal women. Understanding these factors could lead to improved treatment options for affected individuals.

Why it matters

Potential benefit: If successful, this study could provide insights that lead to better management and treatment of urinary incontinence in women with spinal cord injuries.

How similar studies have gone: While studies have explored urinary incontinence in postmenopausal women, this approach focusing on premenopausal women and menstrual cycles is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* women
* age ≥ 18 years
* chronic neurogenic bladder dysfunction due to acquired spinal cord injury
* regular menstrual cycle (26-30 days/cycle)
* written consent given
* UI group only: UI at least once per month

Exclusion Criteria:

* Detrusor overactivity in storage phase above 15cmH20
* Oligomenorrhea or amenorrhea (infrequent or absent menstrual periods)
* Hormonal intake/contraception
* Intake of androgens
* Intake of drugs which interfere with female sex hormones significantly
* Individuals who underwent sex reassignment surgery
* Pregnant or breastfeeding women
* Women who are trying to conceive
* Gynaecological carcinoma
* Endometriosis
* Ovariectomy
* Current pelvic floor physiotherapy
* Reconstructive surgery of bladder
* Local irritation of the bladder, such as bladder tumour, bladder stones, acute urinary tract infection at study start
* Inability to follow study procedures (cognitive or language barriers)

Where it's running

  • Swiss Paraplegic Center
    Nottwil, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.